1,3-Propanediol was a specialty chemical that, due to a novel manufacturing process, is now commercially available in large quantities. Its subchronic toxicity has been evaluated in rats, with special emphasis on potential male reproductive effects. 1,3-Propanediol in deionized water was administered orally by gavage to three groups of 10 male and 10 female Crl:CD(SD)BR rats for a period of 90 consecutive days. Dosage levels were 100, 300, and 1000 mg/kg/day, and a control group received water at a constant volume of 10 ml/kg/day. All animals survived to the scheduled necropsy, and there were no effects on the clinical condition of the animals, body weights, body weight gains, food consumption or organ weights. There were no effects on hematology or serum chemistry parameters. Spermatogenic endpoints were unaffected in all treated males. No treatment-related changes were observed on macroscopic or microscopic examinations of selected organs. Under the conditions of the study, the no-observed-effect level (NOEL) for systemic toxicity of 1,3-propanediol administered orally via gavage to male and female rats for 90 consecutive days was 1000 mg/kg/day, the highest dose tested.
Previous unpublished studies indicate that 1,3-propanediol has a low potential for acute mammalian toxicity. The single dose oral LD 50 in rats was approximately 10 g/kg; the single dose dermal LD 50 in rabbits exceeded 4200 mg/kg; undiluted 1,3-propanediol caused mild transient skin irritation in rabbits on 24-hour occluded exposure, and was practically nonirritant to rabbit eyes; it was not a skin sensitizer in guinea pigs when tested by the Magnusson-Kligman maximization assay (Shell Chemical Company 1977; Magnusson and Kligman 1969) .
The low potential for acute toxicity in proprietary studies con rmed earlier published reports. The oral LD low in rats was reported to be 10 ml/kg (Smyth, Seaton, and Fischer 1941) , and the oral LD 50 in mice was 4773 mg/kg (Holman, Mundy, and Teague 1979) . However, one published report claimed that administration of 1,3-propanediol at 500 ppm in the diet of rats for up to 15 weeks caused crosslinking of DNA in liver and, to a limited extent, in testis (Summer eld and Tappel 1984) . Liver, but not testis, homogenates were able to metabolize 1,3propanediol to malondialdehyde, a reactive crosslinking agent. Malondialdehyde, if formed from 1,3-propanediol, would be expected to be a short-lived metabolic intermediate, with further metabolism to 3-hydroxypropioni c acid and malonic acid.
Hematopoiesis and sperm production might be expected to be sensitive to DNA crosslinking agents produced in vivo. Extensive hematological evaluations and sperm production/morphology were included in this subchronic evaluation of gavaged 1,3propanediol to evaluate if any DNA cross-linking could produce toxic effects. a sealed container at room temperature. The purity of the test material and the concentrations of aqueous dosing solutions were quanti ed using a Hewlett-Packard 6890 gas chromatograph (Wilmington, DE) with FID ( ame ionization detection) detection using a DB-5 (60 M £ 0.32 mm ID, 1 micron lm) capillary column; the initial column temperature was 40 ± C for 8 minutes, then ramped to 275 ± C at 10 ± C/min, with a 10-minute hold. Samples were diluted with tetrohydrofura n containing nbutanol as an internal standard. Under these conditions, retention time for 1,3-propanediol was 16.6 minutes.
Dose Preparation
The appropriate amount of 1,3-propanediol was weighed into a precalibrated, labeled container and deionized water added to the calibration mark. The preparations were stirred continuously throughout the dispensation and dosing procedures using magnetic stir bars and plates. The dosing solutions, including the vehicle, were prepared weekly and were stored refrigerated until dispensation.
Dose Sampling and Analyses
Prior to the study, 10-ml samples were collected from the middle stratum of the low-and high-dose formulations, and stability was determined at 0, 1, 8, and 15 days. During the study samples for concentration veri cation were collected from the middle of each dosing formulation for the rst 4 weeks of dosing and monthly thereafter.
Dose Administration
The test mixtures and vehicle were administered orally by gastric intubation as a single daily dose for 91 or 92 consecutive days through the day prior to the scheduled necropsy. Individual dosages were adjusted weekly based on the most recent body weights, to provide the correct mg/kg/day dose. Table 1 presents the study design.
Animals and Maintenance
Fifty male and 50 female Crl:CD(SD)BR rats, 28 days old, and in apparent good health were received from Charles River Laboratories, Portage, MI, and were uniquely identi ed by Monel metal eartags displaying the permanent identi cation number. All animals were housed for a 12-day acclimation period. Clinical observations were made twice daily for mortality and general changes in appearance or behavior. All animals were housed individually in clean, wire-mesh cages suspended above cage-board. The ration used was PMI Nutrition International Certi ed Rodent LabDiet 5002 (Purina Mills, Inc., New Albany, IN). The diet and reverse osmosis drinking water, delivered by an automatic watering system, were provided ad libitum throughout the study period, except during the period of fasting prior to blood collection when food, but not water, was withheld. All animals were housed in an environmentally controlled room set to maintain temperature at 72 § 4 ± F and a relative humidity of approximately 30-70%. Light timers were set to provide a 12-hour light/12-hour dark photoperiod.
Ninety-Day Toxicity Study
On the day prior to the initiation of dosing, 40 rats per sex were selected for use by a computerized randomization procedure based on body weight strati cation in a block design. The selected animals were approximately 6 weeks old at the initiation of dosing; body weight values ranged from 160 to 201 g for the males and from 138 to 158 g for the females. The animals were observed twice daily for mortality and morbidity. Clinical observations were performed on all animals at the time of dosing and approximately 1 to 2 hours following dosing and prior to euthanasia. Detailed physical examinations were conducted weekly. Individual body weights were recorded weekly, beginning 1 week prior to test article administration. Mean body weight changes were calculated for each study week. A nal (fasted) body weight was recorded for each animal on the day of scheduled necropsy. Individual food consumption was measured weekly beginning 1 week prior to test article administration. Clinical pathology parameters were evaluated on all animals after 4 weeks of dosing and at study termination. The animals were fasted overnight prior to the collection of blood samples. Blood was taken from a lateral tail vein for the interim week 4 collection and from the vena cava at the time of necropsy. Ocular examinations were conducted on all animals using an indirect ophthalmoscope after pupilary dilation prior to the initiation of dosing and during week 12.
Clinical Pathology
Blood was taken from a lateral tail vein for the week 4 collection and from the vena cava at the time of necropsy. Blood for hematology was collected into a tube containing EDTA, blood for coagulation evaluations was collected into a tube containing sodium citrate, and blood for clinical chemistry was collected into a tube with no anticoagulant. Hematology parameters were determined on the whole blood using a Cell-Dyn 3500 CS Automated Hematology Analyzer (Abbott Laboratories, Santa Clara, CA). Coagulation parameters (terminal evaluation only) were determined on citrated plasma using a MLA 1400C Coagulation Analyzer (Medical Laboratory Automations, Inc., Pleasantville, NY). Serum chemistry parameters were determined using a Hitachi 911 Analyzer (Boehringer Mannheim Corp., Indianapolis, IN). Blood smears were prepared to manually verify leukocyte counts and erythrocyte and platelet morphology, if necessary.
Pathology

Macroscopic Examination
A complete necropsy was conducted on all animals at study termination. All animals were euthanized by carbon dioxide asphyxiation followed by exanguination. The necropsy included examination of the external surface, all ori ces and the cranial thoracic, abdominal and pelvic cavities including viscera. At the time of necropsy, the following organs and tissues were collected and preserved in 10% neutral buffered formalin unless otherwise stated: adrenals, aorta, bone with marrow, brain (forebrain, midbrain, hindbrain), coagulating gland, epididymis (right, Bouins), eyes with optic nerves (Davidson's), gastrointestinal tract (esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, rectum), heart, kidneys, liver (section of two lobes), lungs (including bronchi, in ated before with xation), lymph node (mesenteric submandibular), mammary gland (females only), ovaries with oviducts, pancreas, peripheral nerve (sciatic), pituitary, prostate, salivary glands (submaxillary), seminal vesicles, skeletal muscle (vastus medialis), skin, spinal cord (cervical, midthoracic, lumbar), spleen, testis (right, Bouins), thymus, thyroid (with parathyroids), urinary bladder, uterus with vagina, vas deferens, and all gross lesions.
Organ Weights
The following organs from animals euthanized at study termination were weighed: adrenals, brain, epididymides (total and cauda), kidneys, liver, ovaries (with oviducts), pituitary, prostate, seminal vesicles with coagulating glands (with accessory uids), testes, and thyroid. Paired organs were weighed together, except for epididymides and testes. Organ to nal body weight ratios were calculated.
Microscopic Examination
Speci ed tissues were trimmed and tissue samples were processed and embedded in paraf n blocks, which were sectioned at 5 to 8 microns. The tissue sections were stained with hematoxylin and eosin. Tissues listed above were examined from all animals in the vehicle control and 1000 mg/kg/day groups, and the lungs, liver, kidneys, stomach and testes were examined microscopically from all animals in the 100 and 300 mg/kg/day groups.
Spermatogenic Analyses Motility/Viability Analyses
Immediately following euthanasia, the reproductive tract of each male was exposed via a ventral mid-line incision, and the right epididymis was excised and weighed separately. An incision was made in the distal region of the cauda epididymis, and the cauda placed in Dulbecco's phosphate buffered saline (maintained at 37 ± C) with 10 mg/ml bovine serum albumin (BSA). A sample of the diluted sperm was loaded into a 100-l m cannula for determination of motility. As sperm motility can be affected by temperature shock, all cannulas, diluents, and slides were prewarmed and maintained at approximately 37 ± C. Motility determinations were made using the Hamilton-Thorne HTM-Integrated Visual Optical System Version 10 computer-assisted sperm analysis (CASA) system (Beverly, MA). At least 200 motile and nonmotile spermatozoa/animal were analyzed.
Morphology Assessment
A sample of sperm for morphology assessment was obtained from the right cauda epididymis of each male. Sperm morphology was evaluated using a modi cation of the wet-mount technique described by Linder et al. (1992) . Abnormal forms of sperm were recorded from a differential count of 200 spermatozoa/animal.
Enumeration of Epididymal and Testicular Sperm Numbers and Sperm Production Rate
The left testis and epididymis from each male were weighed and frozen, then homogenized and evaluated for sperm production rate using the method described by Blazak, Ernst, and Stewart (1985) . Analyses were performed using the Hamilton-Thorne CASA system.
Statistical Methods
All analyses were conducted using two-tailed tests for minimum signi cance levels of 1% and 5% comparing the treatment groups to the vehicle control group by sex. All means were presented with standard deviations (SD) and the numbers of sampling units (N ) used to calculate the means. All statistical tests were performed by a Digital MicroVAX 3400 computer with appropriate programming. Body weight, body weight change, food consumption, clinical pathology, absolute and relative organ weight data and epididymal and testicular sperm numbers (22) Results are the mean (standard deviation) of 10 rats per sex at each dose. No weights were statistically different from corresponding control using Dunnett's test. and sperm production rates were subjected to a one-way analysis of variance (ANOVA), followed by Dunnett's test. The percentage of motile spermatozoa and the percentage of sperm with normal morphology were analyzed by the Kruskal-Wallis test. 
RESULTS
Analytical Chemistry
One and 10% concentrations of 1,3-propanediol in water were stable for up to 15 days. Dosing solutions were generally within 20% of nominal at the 10 mg/ml concentration and within 4% at the 30 and 100 mg/ml concentrations (data not shown).
Clinical Observations and Survival
All animals survived to the scheduled necropsy, and no treatment-related clinical signs were observed in any group. Clinical signs observed in the treated groups were noted similarly in the control or were present in a non-dose-related manner.
Body Weights
Mean body weights and body weight gains were unaffected at all dose levels (Table 2) . A statistical signi cant ( p < .05) increase in mean body weight gain for the 300 mg/kg/day group males during weeks 6 to 7 was attributed to the substantial body weight gain (42 g) for a single animal. All other values in the treated groups were similar to those in the control group.
Food Consumption
No test article-related effects on food consumption were observed in any of the treated groups. Mean food consumption values in the treated groups were comparable to the control group (data not shown).
Clinical Pathology Hematology
No test article-related changes were observed in hematology parameters for any of the treated groups at the week 4 or 13 evaluations. Several statistically signi cant differences from the control group values were observed in white blood cell parameters (Table 3) . Mean white blood cell and/or lymphocyte counts for all treated males were decreased at the week 4 evaluation (Table 3) . However, there was no apparent dose response relationship, and the differences were attributed to a high control group value and not the test article. The mean absolute lymphocyte value for the 1000 mg/kg/day group females was slightly increased at the week 13 evaluation (data not shown). However, the value was similar to the week 4 value for this group, i.e., was not increased relative to time on study, and a similar increase was not observed in the males. Therefore, no relationship to treatment was evident.
Serum Chemistry
No treatment-related changes were present in serum chemistry parameters for any of the treated groups at the week 4 or 13 evaluations. However, comparison to the control values at both evaluations revealed several statistically signi cant differences for the treated females. At week 4, slight decreases were observed in mean aspartate aminotransferase at 300 and 1000 mg/kg/day, in mean cholesterol at 100 mg/kg/day, and in mean chloride at 1000 mg/kg/day. Glucose was increased at all dose levels (data not shown). In general, these parameters are highly variable and all differences from the control group values were slight and/or were not present in a dose-related manner. In addition, similar changes were not evident for any of these parameters at the week 13 evaluation (Table 4) . At week 13, total bilirubin was decreased in the females at 100 Sperm was collected from the left testis and epididymus. Results are the mean (standard deviation) of ten rats at each dose. a No parameters were statistically different from the corresponding control.
b Sperm production rate = number of sperm/g testis/6.1 days (rate of turnover of germinal epithelium). and 1000 mg/kg/day. However, slight decreases in bilirubin are generally not of toxicological signi cance.
Pathology
No treatment-related gross ndings were observed in any of the treated animals at the scheduled necropsy. No remarkable differences in mean organ weight data were observed (data not shown). No treatment-related changes were observed in any tissue examined microscopically. All ndings were regarded as common, spontaneous lesions in laboratory rats.
Spermatogenic Evaluations
No treatment-related effects on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production rate and sperm motility and morphology) were observed at any dose level (Table 5) . Differences between the control and treated groups were slight and were not statistically signi cant.
DISCUSSION
Oral administration of 1,3-propanediol for 90 days to rats at doses up to 1000 mg/kg/day did not cause any apparent systemic toxicity. All animals survived to the scheduled necropsy. No treatment-related changes in the clinical condition of the animals were observed. Mean body weights, body weight gains, food consumption, clinical pathology parameters (hematology, serum chemistry), and organ weights were unaffected by administration of 1,3-propanediol . Spermatogenic endpoints (testicular and epididymal sperm numbers, sperm production rate, and sperm motility and morphology) were also unaffected in all treated males. No treatment-related changes were observed in any organ on macroscopic or microscopic examination. This study con rmed the low potential for subchronic toxicity of 1,3-propanediol as indicated by the preliminary acute studies. One previous study (Summer eld and Tappel 1984) reported that administration of 1,3-propanediol in the diet caused DNA crosslinking in rats. The present study was not designed to measure DNA crosslinking. However, if such crosslinking did occur, it did not cause any adverse functional effect on the hematopoietic or spermatogenic systems, two systems which, because of active DNA transcription and translation processes, might be expected to be especially susceptible. Also, there were no apparent pathological or functional effects in the liver, as determined by histopathology and clinical chemistry; the liver is the organ in which the putative crosslinking agent malondialdehyde is most likely to be formed by metabolism from 1,3-propanediol . The previous study was conducted by dietary incorporation of 500 ppm 1,3-propanediol for 15 weeks, and in this study it was administered by gavage at daily doses up to 1 g/kg; however, this dosing difference is not likely to account for the apparent lack of any toxic effects which might occur as a result of any DNA crosslinking in this study. Under the conditions of this study, malondialdehyde formation and DNA crosslinking are not likely to have occurred to a signi cant extent.
In conclusion, the no-observed-effect level (NOEL) for systemic toxicity of 1,3-propanediol administered orally via gavage to male and female rats for 90 consecutive days was 1000 mg/kg/ day, the highest dose tested.
